The Cooling Sensation Safe Deglution Study

Launched by FUNDACIÓN PÚBLICA ANDALUZA PARA LA INVESTIGACIÓN DE MÁLAGA EN BIOMEDICINA Y SALUD · Apr 14, 2025

Keywords

ClinConnect Summary

The Cooling Sensation Safe Deglution Study is looking at a new type of nutritional supplement to help patients who have difficulty swallowing (a condition known as dysphagia) after having a stroke. Dysphagia can lead to serious problems like malnutrition and respiratory infections, making recovery harder. This study will use thickened, flavored nutritional drinks like mango-mint and lemon-mint to see if they help improve swallowing safety and make it easier for patients to enjoy their food. Previous research suggests that flavors and cold sensations can stimulate nerves in the throat to help with swallowing.

To participate in this study, you need to be an adult over 18 years old, currently hospitalized for a stroke, and diagnosed with dysphagia. You should also be at risk of malnutrition and able to understand and answer questions related to the study. If you join, you'll be asked to try these new flavored supplements and share your experiences. This study is not yet recruiting participants, but it aims to find effective ways to enhance swallowing safety for stroke survivors.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Men and women over 18 years old.
• • Currently hospitalized due to an acute stroke.
• • Confirmed diagnosis of dysphagia through V-VST (Volume-Viscosity Swallow Test).
• • Ability to collaborate and respond to questionnaire questions and other research tools used in the study.
• • Malnutrition or risk of malnutrition, requiring a thickened, high-calorie, high-protein ONS, as determined by medical assessment in routine clinical practice.
• • Voluntary written informed consent to participate in the study.
• Exclusion Criteria:
• • Moderate to severe cognitive impairment that interferes with the correct interpretation of the study or its requirements.
• • Diagnosis of advanced dementia, severe psychiatric illness, or any other central nervous system condition that impairs the patient's comprehension of the study.
• • Sociocultural, linguistic, intellectual, or other factors that hinder the patient's proper understanding of the study.
• • Diagnosis of galactosemia.
• • Intolerance or refusal (for any reason) of oral nutritional supplements.
• • Requirement for parenteral nutrition or contraindication to oral intake.
• • Severe active renal, hepatic, or gastrointestinal diseases that contraindicate the use of ONS